DE69127541D1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number
DE69127541D1
DE69127541D1 DE69127541T DE69127541T DE69127541D1 DE 69127541 D1 DE69127541 D1 DE 69127541D1 DE 69127541 T DE69127541 T DE 69127541T DE 69127541 T DE69127541 T DE 69127541T DE 69127541 D1 DE69127541 D1 DE 69127541D1
Authority
DE
Germany
Prior art keywords
mmoles
pharmaceutical composition
phosphorus
zinc
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69127541T
Other languages
English (en)
Other versions
DE69127541T2 (de
Inventor
Andras Sikter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S & V Engineering Kft
Original Assignee
S & V Engineering Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S & V Engineering Kft filed Critical S & V Engineering Kft
Publication of DE69127541D1 publication Critical patent/DE69127541D1/de
Application granted granted Critical
Publication of DE69127541T2 publication Critical patent/DE69127541T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69127541T 1990-05-10 1991-05-10 Pharmazeutische zusammensetzung Expired - Fee Related DE69127541T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU902980A HU207800B (en) 1990-05-10 1990-05-10 Process for producing composition for improving condition and for treating different illnesses
PCT/HU1991/000018 WO1991016909A1 (en) 1990-05-10 1991-05-10 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE69127541D1 true DE69127541D1 (de) 1997-10-09
DE69127541T2 DE69127541T2 (de) 1998-04-02

Family

ID=10961983

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127541T Expired - Fee Related DE69127541T2 (de) 1990-05-10 1991-05-10 Pharmazeutische zusammensetzung

Country Status (8)

Country Link
US (1) US5348749A (de)
EP (1) EP0530220B1 (de)
AT (1) ATE157543T1 (de)
AU (1) AU651824B2 (de)
CA (1) CA2082275A1 (de)
DE (1) DE69127541T2 (de)
HU (1) HU207800B (de)
WO (1) WO1991016909A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970008105B1 (ko) * 1993-06-28 1997-05-21 주식회사 미원 L-아스파테이트 또는 아스파라긴을 유효성분으로 함유하는 알콜성 장해 보호제 및 그의 제조방법
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
EP1377300A1 (de) * 2001-04-04 2004-01-07 Henry Fliss Verwendung von zinkionophoren zur behandlung von stress
EP1249244A1 (de) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutische Zusammensetzungen zur Behandlung einer g-actin / f-actin-gleichgewicht vermittelten Erkrankung, z.b. einer respiratorischen Erkrankung
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
US7129375B2 (en) * 2002-10-16 2006-10-31 Zinpro Corporation Metal complexes of α amino dicarboxylic acids

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060601B2 (de) * 1970-09-02 1980-05-22 V. Berthelsen Industrial Commercial Co. A/S, Hellerup (Daenemark) Nahrungsergänzungsmittel
IL61080A0 (en) * 1980-09-19 1980-11-30 Garfinkel D Pharmaceutical composition containing zinc ions
EP0053244A1 (de) * 1980-12-03 1982-06-09 Dr. Franz Köhler Chemie KG Präparat zur Verhütung der EPH-Gestose und andern Stoffwechselstörungen während der Schwangerschaft
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
IT1177384B (it) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione
US4582709A (en) * 1985-02-08 1986-04-15 Warner-Lambert Company Chewable mineral supplement
SE468074B (sv) * 1985-11-22 1992-11-02 Medina Hb Preparat foer foerbaettring av den cellulaera metabolismen
EP0245669B1 (de) * 1986-05-14 1993-12-01 Medopharm Arzneimittelwerk Dr. Zillich GmbH & Co. Pharmazeutisches Präparat zur Verhütung der Schädigung lebender Zellen durch freie Radikale, beziehungsweise zur Erhöhung der Wirksamkeit von organischen Schwefelverbindungen und Verfahren zur Erhöhung der Lebensdauer isolierter Organe
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken

Also Published As

Publication number Publication date
EP0530220B1 (de) 1997-09-03
WO1991016909A1 (en) 1991-11-14
EP0530220A1 (de) 1993-03-10
HUT57597A (en) 1991-12-30
US5348749A (en) 1994-09-20
AU651824B2 (en) 1994-08-04
CA2082275A1 (en) 1991-11-11
ATE157543T1 (de) 1997-09-15
AU7767591A (en) 1991-11-27
HU207800B (en) 1993-06-28
HU902980D0 (en) 1990-09-28
DE69127541T2 (de) 1998-04-02

Similar Documents

Publication Publication Date Title
AU1537095A (en) Therapeutic agents containing thyroid hormones
PL326149A1 (en) Pharmaceutic dipeptides containing angiostatic agents and methods of their application
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
MX9700081A (es) Composiciones farmaceuticas de tacrina.
NO923859L (no) Medikament
ZA938274B (en) Compositions of oak bark extract related synthetic compositions and method of using same
ATE289197T1 (de) Nicotinsäure zusammensetzungen enthaltender starterkit
AU573262B2 (en) Covalently bound heparin-antithrombin iii complex
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
DE69332378T2 (de) Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
ATE157543T1 (de) Pharmazeutische zusammensetzung
DE59410275D1 (de) Deuterierte wirkstoffe in transdermaler applikation
GR3030262T3 (en) Compositions and methods using unbound mpl receptor for stimulating platelet production
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
KR910009267A (ko) 우울증의 치료방법
DE3687838D1 (de) Deodorant-bettmaterial.
WO2001042205A3 (en) Treatment of inflammatory bowel disease with vitamin d compounds
EP0572549A4 (de)
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
UA29325A (uk) Спосіб профілактики і лікування карієсу зубів у дітей
BG95739A (en) Means for the potentiation of the cyclophosphamide effect in intralesion application in solid malignant tumours
NO930820L (no) Patogen-spesifikk ctl terapi
MX9706404A (es) Metodo para tratar deplecion de adenosina.
RU92016374A (ru) Фармацевтическая композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)
8339 Ceased/non-payment of the annual fee